Related Experiment Video
Updated: Jun 21, 2026

08:51
Data Acquisition and Analysis In Brainstem Evoked Response Audiometry In Mice
Published on: May 10, 2019
Modified sound-evoked brainstem potentials in Foxp2 mutant mice.
Simone Kurt1, Matthias Groszer, Simon E Fisher
1Institute of Neurobiology, University of Ulm, D-89069 Ulm, Germany.
Brain Research
|July 15, 2009
Summary
The FOXP2 gene impacts speech and language. A specific mutation (R552H) in Foxp2 mice affects auditory brainstem responses, suggesting a role for Foxp2 in auditory system development and function.
Area of Science:
- Neuroscience
- Genetics
- Speech and Language Disorders
Background:
- Heterozygous mutations in the human FOXP2 gene are linked to developmental speech and language disorders.
- Previous research focused on motor control circuits, but Foxp2 is also expressed in auditory pathways.
- Auditory processing deficits may contribute to speech learning and production difficulties.
Purpose of the Study:
- To investigate the role of Foxp2 in auditory processing using mouse models of FOXP2-related speech/language impairment.
- To assess auditory brainstem responses (ABR) in mice with distinct Foxp2 mutations.
Main Methods:
- Auditory brainstem responses (ABR) were recorded in two heterozygous mouse models with different Foxp2 point mutations.
- Comparison of ABRs between mutant mice and wildtype littermates.
Main Results:
- Mice with a Foxp2-S321X nonsense mutation showed no significant ABR differences from wildtypes.
- Mice with a Foxp2-R552H missense mutation exhibited altered ABR waves, including longer latencies and smaller amplitudes.
- These alterations suggest potential impacts on synaptic transmission synchrony or neuronal activation in the auditory system.
Conclusions:
- Auditory processing deficits up to the midbrain are unlikely to be the primary cause of FOXP2-related language impairments.
- The R552H mutation highlights a potential role for Foxp2 in auditory system development and function.
- Systematic auditory function testing in humans with FOXP2 mutations is warranted, given the accessibility of ABR audiometry.
